title: Risk Factors for Degree and Type of Sequelae After Involution of Untreated Hemangiomas of Infancy.
abstract: Infantile hemangiomas involute to some extent, but they often leave sequelae that may cause disfigurement. Factors determining the risk of permanent sequelae after regression are of crucial importance in treatment decision making.
  
  
  
  To describe the sequelae left by infantile hemangiomas after natural involution and to identify clinical characteristics that could predict the most severe or a particular type of sequelae.
  
  
  
  Multicentric retrospective cohort study of images from 187 infantile hemangiomas that had not received systemic treatment and had follow-up pictures until regression that were selected from photographic files taken between 2003 and 2013 at 4 university hospitals with large vascular clinics in 3 different countries.
  
  
  
  Outcome measures were the type of sequelae classified as residual telangiectasia, anetodermal skin, redundant skin, persistent superficial component, and the degree of sequelae ranging from 1 to 4.
  
  
  
  A total of 184 hemangiomas were included. The overall incidence of significant sequelae was 101 of 184 (54.9%). The most common sequelae after involution were telangiectasias (145, 84.3%), fibrofatty tissue (81, 47.1%), and anetodermic skin (56, 32.6%). The average age at which hemangioma completed involution was 3.5 years. Superficial and deep hemangiomas left significantly fewer sequelae than combined hemangiomas (Mann-Whitney; superficial vs deep, OR, 1.6; 95% CI, 0.6-3.8; P = .81; superficial vs combined, OR, 3.3; 95% CI, 1.7-6.3; P < .001; deep vs combined, OR, 2.1; 95% CI, 0.9-5.1; P < .001). Hemangiomas with a step or abrupt border of the superficial component left more severe sequelae than those with a smooth border (χ2,OR, 3.4; 95% CI, 1.8-6.6; P < .001). Superficial hemangiomas with a cobblestone appearance or rough surface left more severe sequelae than those with a smooth surface (Kruskal-Wallis; α, 0.05; P < .001). Using multivariate analysis, combined hemangiomas with a superficial component and a step border were associated with more sequelae.
  
  
  
  In this retrospective study of sequelae in a large cohort of untreated infants, we quantified the prevalence of permanent scarring and identified clinical features predictive of permanent sequelae. Our observations provide useful information at a time when the treatment paradigm for hemangiomas has changed. Such knowledge may help primary care physicians predict the risk of sequelae and identify high-risk lesions to implement early treatment.
authors.affiliation: Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: Eulalia
authors.initials: E
authors.lastname: Baselga
authors.affiliation: Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: Esther
authors.initials: E
authors.lastname: Roe
authors.affiliation: Center for Vascular Anomalies, Division of Plastic Surgery, Cliniques Universitaires St Luc, Brussels, Belgium.
authors.forename: Julien
authors.initials: J
authors.lastname: Coulie
authors.affiliation: Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: Fania Z
authors.initials: FZ
authors.lastname: Muñoz
authors.affiliation: Center for Vascular Anomalies, Division of Plastic Surgery, Cliniques Universitaires St Luc, Brussels, Belgium.
authors.forename: Laurence M
authors.initials: LM
authors.lastname: Boon
authors.affiliation: Division of Dermatology (Pediatrics) CHU Sainte-Justine, University of Montreal, Montreal, Canada.
authors.forename: Catherine
authors.initials: C
authors.lastname: McCuaig
authors.affiliation: Department of Dermatology, Hospital Infantil Universitario del Niño Jesús, Madrid, Spain.
authors.forename: Angela
authors.initials: A
authors.lastname: Hernandez-Martín
authors.affiliation: Department of Clinical Epidemiology; CIM-Caiber-IIb Sant Pau, Barcelona Spain.
authors.forename: Ignasi
authors.initials: I
authors.lastname: Gich
authors.affiliation: Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
authors.forename: Luis
authors.initials: L
authors.lastname: Puig
mesh_terms: D057088:Anetoderma / Q000209:etiology; D002675:Child, Preschool; D003657:Decision Making; D018450:Disease Progression; D042241:Early Diagnosis; D005500:Follow-Up Studies; D006391:Hemangioma / Q000150:complications / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D006785:Hospitals, University; D006801:Humans; D015994:Incidence; D007223:Infant; D015995:Prevalence; D011379:Prognosis; D012017:Referral and Consultation; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D012878:Skin Neoplasms / Q000150:complications / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D013030:Spain / Q000453:epidemiology; D013684:Telangiectasis / Q000209:etiology; D016896:Treatment Outcome